267 related articles for article (PubMed ID: 19124378)
1. Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma.
Lindmark B
Ther Adv Respir Dis; 2008 Oct; 2(5):279-99. PubMed ID: 19124378
[TBL] [Abstract][Full Text] [Related]
2. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
3. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
[TBL] [Abstract][Full Text] [Related]
4. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma.
Buhl R; Vogelmeier C
Curr Med Res Opin; 2007 Aug; 23(8):1867-78. PubMed ID: 17605896
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy in asthma--fixed or variable dosing in different patients?
Lötvall J
Curr Med Res Opin; 2004 Nov; 20(11):1711-27. PubMed ID: 15537472
[TBL] [Abstract][Full Text] [Related]
6. [symbol: see text] Seretide and [symbol: see text] Symbicort in asthma management.
Drug Ther Bull; 2002 Aug; 40(8):62-4. PubMed ID: 12216339
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and small airway impairment in patients who need to step-up from inhaled corticosteroid monotherapy.
Hozawa S; Terada M; Hozawa M
Pulm Pharmacol Ther; 2014 Apr; 27(2):190-6. PubMed ID: 24388868
[TBL] [Abstract][Full Text] [Related]
8. Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
Tamm M; Richards DH; Beghé B; Fabbri L
Respir Med; 2012 Dec; 106 Suppl 1():S9-19. PubMed ID: 23273165
[TBL] [Abstract][Full Text] [Related]
9. Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.
Ankerst J
J Asthma; 2005 Nov; 42(9):715-24. PubMed ID: 16316864
[TBL] [Abstract][Full Text] [Related]
10. Budesonide/formoterol maintenance and reliever therapy versus conventional best practice.
Demoly P; Louis R; Søes-Petersen U; Naya I; Carlsheimer A; Worth H; Almeida J; Sears MR
Respir Med; 2009 Nov; 103(11):1623-32. PubMed ID: 19762222
[TBL] [Abstract][Full Text] [Related]
11. The long and short of beta2-agonists.
Lötvall J
Pulm Pharmacol Ther; 2002; 15(6):497-501. PubMed ID: 12493336
[TBL] [Abstract][Full Text] [Related]
12. Current trends in asthma therapy.
Sztanke K; Pasternak K
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):290-3. PubMed ID: 15323207
[TBL] [Abstract][Full Text] [Related]
13. Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention.
Aalbers R; Vogelmeier C; Kuna P
Respir Med; 2016 Feb; 111():1-7. PubMed ID: 26614594
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
Kim D; Glaum M; Lockey R
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
[TBL] [Abstract][Full Text] [Related]
15. Short-acting beta 2-agonist and oral corticosteroid use in asthma patients prescribed either concurrent beclomethasone and long-acting beta 2-agonist or salmeterol/fluticasone propionate combination.
Angus R; Reagon R; Cheesbrough A
Int J Clin Pract; 2005 Feb; 59(2):156-62. PubMed ID: 15854190
[TBL] [Abstract][Full Text] [Related]
16. Budesonide prevents cytokine-induced decrease of the relaxant responses to formoterol and terbutaline, but not to salmeterol, in mouse trachea.
Adner M; Larsson B; Säfholm J; Naya I; Miller-Larsson A
J Pharmacol Exp Ther; 2010 Apr; 333(1):273-80. PubMed ID: 20061444
[TBL] [Abstract][Full Text] [Related]
17. Budesonide/formoterol for maintenance and reliever therapy of asthma: a meta analysis of randomised controlled trials.
Edwards SJ; von Maltzahn R; Naya IP; Harrison T
Int J Clin Pract; 2010 Apr; 64(5):619-27. PubMed ID: 20456215
[TBL] [Abstract][Full Text] [Related]
18. Fluticasone/formoterol: a new single-aerosol combination therapy for patients with asthma.
Dissanayake S; Grothe B; Kaiser K
Respir Med; 2012 Dec; 106 Suppl 1():S20-8. PubMed ID: 23273163
[TBL] [Abstract][Full Text] [Related]
19. Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma.
Beasley R; Harper J; Bird G; Dunphy H; Semprini A; Pavord ID; Papi A; Weatherall M
BMC Pulm Med; 2019 Dec; 19(1):264. PubMed ID: 31883519
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of combination therapies in asthma: an observational study.
Suissa S; Dell'Aniello S; Ernst P
Pulm Pharmacol Ther; 2009 Jun; 22(3):194-8. PubMed ID: 19063985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
